Evaluating the timing of syncope and asystole during tilt table testing
Official title: NeuroArrhythmias Area Registry of AIAC (NAARA) Syncope-Asystole Latency Time in Tilt Table Test (SALT-TILT) Study
Run by Azienda Ospedaliera di Bolzano · NCT06356207 · Data updated 2026-11-12
This study is testing if the timing of fainting during a tilt table test can help predict how well a pacemaker will work for people with reflex syncope.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 64 (estimated) |
| Sponsor | Azienda Ospedaliera di Bolzano Academic / other |
| Locations | 1 site (Bolzano) |
| Status | Recruiting |
| Started | March 20, 2024 |
| Main results expected | March 2026 |
| Study ends | March 2027 |
| Registry record updated | April 11, 2024 |
| Trial ID | NCT06356207 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients eligible for invasive treatment of reflex syncope according to established guidelines.
✕Probably not a fit
Patients with syncope caused by conditions other than reflex syncope or those with structural heart disease may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the relationship between the timing of loss of consciousness and the onset of asystole during a tilt table test in patients with reflex syncope. It aims to determine if the latency time can predict the effectiveness of pacemaker therapy in preventing syncope recurrences. The study will follow patients for two years and utilize a registry to collect data on their responses to invasive treatments. The hypothesis is that a vasodepressive component may hinder the efficacy of pacing, leading to continued syncope despite a stable heart rhythm.
Why it matters
Potential benefit: If successful, this study could improve the selection criteria for pacemaker implantation, potentially reducing syncope recurrences in patients.
How similar studies have gone: While the approach of evaluating syncope timing is novel, similar studies have shown promise in understanding syncope mechanisms and improving treatment outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients eligible for invasive treatment according to the ESC Guidelines for pacing 2021 * Written informed consent Exclusion Criteria: * Other condition which explains syncope cause other than reflex syncope * Structural heart disease (valvular, ischaemic, cardiomyopathies) * Pregnancy * Patient denial to be recorded on video during tilt table test
Where it's running
-
Azienda Sanitaria di Bolzano
Bolzano, Italy Recruiting
Study contacts
- Study coordinator: Matthias Unterhuber, Dr. Dr.
- Email: matthias.unterhuber@gmail.com
- Phone: 0471 43 9950
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Whole-body bedside ultrasound in older adults after a fall
This study tests whether doing a full-body ultrasound at the bedside changes how doctors manage older adults (65+) who come to the emergency department after a fall.
-
Risk of malignant arrhythmias after acute coronary syndrome
This study tracks how often dangerous heart rhythms occur in adults admitted for ACS and looks for patterns that might predict them.
-
SPIKE FLOW endocardial pacing lead safety and performance study
This study tests whether the SPIKE FLOW temporary endocardial pacing lead is safe and effective in adults needing temporary pacing during heart-related conditions.
-
3D Echocardiography to See How CIEDs May Worsen Tricuspid Regurgitation
This study tests whether different CIEDs (leadless pacemakers, LBBaP, and conventional pacemakers) differ in causing worsening tricuspid regurgitation, using 3D heart imaging.
-
Higher pacemaker rate for people with cardiac amyloidosis
This study will see if temporarily increasing the pacemaker rate improves heart-failure symptoms and exercise tolerance in adults with cardiac amyloidosis who already have pacemakers.
-
Do medicines that lengthen the heart's QT interval cause serious heart problems in hospitalized adults?
This project will test whether commonly used hospital medicines that can prolong the heart's QT interval lead to serious cardiac events in adults admitted to Ontario hospitals.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.